News
Novo Nordisk will sell a less expensive one-month supply of Wegovy for patients who previously took compounded versions of ...
If you're one of the millions of Americans who have used or thought about using GLP-1 weight-loss drugs, it’s important to ...
The suit comes amid recent studies showing a link between vision complications and people taking drugs containing semaglutide ...
Evernorth has capped antiobesity drug monthly co-pays at $200 in a move to improve access and affordability amid new drug ...
Cigna Group’s drug benefit unit is offering a new way for health plans to cover expensive weight-loss drugs that it says will ...
Report from Canada’s Drug Agency says Wegovy cuts risk of heart attack, stroke or cardiovascular death by 20 per cent ...
Pharma giant Eli Lilly’s weight loss drug Mounjaro is priced between Rs. 10,000- ₹15,000 in India making it inaccessible to a ...
3d
ZME Science on MSNPatients on Weight Loss Drugs Like Wegovy May Say They Just Don’t Want to Drink AnymoreOn a weekday morning in Dublin, a group of patients walked into a weight-loss clinic hoping to shed pounds. What they didn’t expect was to also lose their taste for alcohol. A new study has found that ...
Researchers are beginning to wonder whether blockbuster drugs such as Wegovy, Ozempic and Zepbound could play a role in ...
3d
Edinburgh News on MSNScotland tops UK weight loss rankings in new Voy and Imperial studyA major study reveals Scots are losing more weight than anyone else in the UK – and it’s not just down to medication, say ...
Researchers found GLP-1s may modestly reduce the risk of 14 obesity-related cancers, especially colorectal cancer, when compared to a weight-neutral medication used to treat diabetes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results